Acute and post-acute behavioral and psychological effects of salvinorin A in humans

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Psychopharmacology

• Publication date

  2011-09-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-011-2470-6PMID 21901316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers

  2011cited by this paper
• Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.

  2011influential reference
• Salvia divinorum: effects and use among YouTube users.

  2010cited by this paper
• Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats.

  2010cited by this paper
• The discriminative effects of the κ-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects

  2010cited by this paper
• Use patterns and self-reported effects of Salvia divinorum: an internet-based survey.

  2010influential reference
• Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial

  2010cited by this paper
• Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents

  2010cited by this paper
• Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats

  2009cited by this paper
• Human hallucinogen research: guidelines for safety

  2008influential reference
• Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers

  2008cited by this paper
• Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan.

  2008cited by this paper
• Discriminative Stimulus Effects of 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane in Rhesus Monkeys

  2008cited by this paper
• The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.

  2007cited by this paper
• Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.

  2006cited by this paper
• Pattern of use and subjective effects of Salvia divinorum among recreational users.

  2006cited by this paper
• Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

  2006cited by this paper
• Analysis of the Psychoactive Terpenoid Salvinorin A Content in Five Salvia divinorum Herbal Products

  2006cited by this paper
• The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

  2006cited by this paper
• Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

  2005cited by this paper
• Quantification of the plant-derived hallucinogen Salvinorin A in conventional and non-conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking.

  2005cited by this paper
• The plant-derived hallucinogen, salvinorin A, produces κ-opioid agonist-like discriminative effects in rhesus monkeys

  2004cited by this paper
• SPSS Explained

  2004cited by this paper
• The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.

  2004cited by this paper
• Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography

  2004cited by this paper
• Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A

  2003cited by this paper
• Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.

  2002cited by this paper
• Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

  2002cited by this paper
• Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up.

  2002cited by this paper
• Psychometric assessment of the Hallucinogen Rating Scale.

  2001cited by this paper
• Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans

  2001cited by this paper
• Psychedelic Effects of Ketamine in Healthy Volunteers: Relationship to Steady‐state Plasma Concentrations

  1998cited by this paper
• Ethnopharmacognosy and human pharmacology of Salvia divinorum and salvinorin A

  1995cited by this paper
• Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

  1994cited by this paper
• Salvia divinorum and salvinorin A: new pharmacologic findings.

  1994cited by this paper
• Psychotomimesis mediated by kappa opiate receptors

  1986cited by this paper
• Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers

  year unknowncited by this paper

• Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis

  2025cites this paper
• Kappa opioid receptor control of motivated behavior revisited

  2025cites this paper
• Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A

  2024cites this paper
• The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample

  2024cites this paper
• A Focused Review on Cognitive Improvement by the Genus Salvia L. (Sage)—From Ethnopharmacology to Clinical Evidence

  2023cites this paper
• Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD

  2022cites this paper
• Revista ConCiencia EPG–Edición Especial Marzo 2022 ISSN digital: 2517-9896

  2022cites this paper
• The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies

  2022cites this paper
• Salvinorin A for Stroke Rescue Purposes

  2022cites this paper
• The Altered States Database: Psychometric data from a systematic literature review

  2022cites this paper
• Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.

  2021cites this paper
• Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects

  2021influential citation
• Models of psychedelic drug action: modulation of cortical-subcortical circuits.

  2021cites this paper
• Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users

  2021cites this paper
• The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A

  2021cites this paper
• Relevance of the Kappa Dynorphin System to Schizophrenia and Its Therapeutics

  2021cites this paper
• Therapeutic Use of Hallucinogens

  2021cites this paper
• The drug likeness analysis of anti-inflammatory clerodane diterpenoids

  2020cites this paper
• The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain

  2020cites this paper
• The Role of Dynorphin and the Kappa Opioid Receptor in Schizophrenia and Major Depressive Disorder: A Translational Approach.

  2020cites this paper
• The Pharmacology of Visual Hallucinations in Synucleinopathies

  2019influential citation
• The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence.

  2019cites this paper
• Neuropharmacological modulation of the aberrant bodily self through psychedelics.

  2019cites this paper
• Investigating the antinociceptive effects of N-docosahexaenoyl ethanolamine and novel kappa opioid receptor agonists

  2018cites this paper
• The Use of Salvia divinorum from a Mazatec Perspective

  2018cites this paper
• Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence

  2018influential citation
• Designer drugs: Review and implications for emergency management

  2018cites this paper
• Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

  2018cites this paper
• Salvinorin A reduces neuropathic nociception in the insular cortex of the rat

  2018cites this paper
• Looking for the Self: Phenomenology, Neurophysiology and Philosophical Significance of Drug-induced Ego Dissolution

  2017cites this paper
• Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats.

  2017cites this paper
• Molecular Characterization of the Opioid Receptors: Design, Development, and Preclinical Evaluation of Salvinorin A-Based Molecular Probes.

  2017cites this paper
• Behavioral and Psychological Effects of Salvia divinorum

  2016cites this paper
• The "legal highs" of novel drugs of abuse

  2016cites this paper
• Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.

  2016cites this paper
• Kappa Opioids, Salvinorin A and Major Depressive Disorder

  2016cites this paper
• Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans

  2016cites this paper
• Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens

  2016cites this paper
• Clinical applications of hallucinogens: A review.

  2016influential citation
• Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions.

  2016cites this paper
• Salvia divinorum: An overview of the usage, misuse, and addiction processes

  2016influential citation
• Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans

  2016cites this paper
• The Plant Salvia divinorum (Lamiaceae)—Chemistry and Pharmacology

  2016cites this paper
• The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series

  2015cites this paper
• Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

  2015cites this paper
• The subjective experience of acute, experimentally-induced Salvia divinorum inebriation

  2015influential citation
• Salvinorin a and related compounds as therapeutic drugs for psychostimulant-related disorders.

  2015influential citation
• Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans

  2015cites this paper
• Salvinorin-A induces intense dissociative effects , blocking external sensory perception and modulating interoception and sense of body ownership in humans Regular research article

  2015cites this paper
• Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.

  2015cites this paper
• Salvia divinorum e seus efeitos biológicos: “A critical review on the toxicity of Salvia divinorum and its major constituent Salvinorin A”

  2015cites this paper
• Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

  2015cites this paper
• From local to global-fifty years of research on Salvia divinorum.

  2014cites this paper
• The claustrum’s proposed role in consciousness is supported by the effect and target localization of Salvia divinorum

  2014cites this paper
• Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat

  2014cites this paper
• Salvinorin A: Example of a Non- Alkaloidal Bioactive Opioid from a Plant Source

  2014cites this paper
• Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans

  2014cites this paper
• Altered States of Consciousness and Transpersonal Psychology

  2013cites this paper
• Endogenous opiates and behavior: 2012.

  2013cites this paper
• Characterization of human TRPA1 and TRPV1 channels in response to naturally occurring defensive compounds

  2013cites this paper
• Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug

  2013cites this paper
• Investigations Of Salvinorin A: Synthetic Isolation, Quantification, And In Vivo Characteristics

  2013cites this paper
• Psychoactive substances present in Salvia divinorum acquired in smartshops or in the Internet

  2013influential citation
• Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.

  2012cites this paper
• Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

  2012cites this paper
• Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects

  2012cites this paper
• High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

  2012cites this paper
• Investigation of Natural Product Scaffolds for the Development of Opioid Receptor Ligands

  2012cites this paper